(Q36434769)

English

Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

author name string

M Niimoto

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

T Hattori

2

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

R Tamada

3

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

K Sugimachi

4

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

K Inokuchi

5

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

N Ogawa

6

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

publication date

1 November 1988

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

The Japanese Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

681-686

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Postoperative adjuvant chemotherapy for gastric carcinoma. Analysis of data on 1805 patients followed for 5 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/3150019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/3150019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-operative long-term adjuvant immunochemotherapy with mitomycin-C, PSK and FT-207 in gastric cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3150019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levamisole in postoperative adjuvant immunochemotherapy for gastric cancer. A randomized controlled study of the MMC + Tegafur regimen with or without levamisole. Report I

1 reference

https://pubmed.ncbi.nlm.nih.gov/3150019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A controlled study of surgical adjuvant chemoimmunotherapy with FT-207 and OK-432 for advanced stomach cancer: the fourth study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3150019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3150019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02471530

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36434769&oldid=1630607538"